Trademark Details For FUNGAFLOR (Serial Number 73252548)

  •  Home
  •  Print
FUNGAFLOR
9
45
21
0
Serial Number  United States - USPTO 73252548
Registration Number 1201735
Mark
FUNGAFLOR
Filing Date Mar-03-1980
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0



  • Mark Literal Elements:

005Pharmaceuticals

U.S Class(es): 006

Class Status: Active





Correspondences

NameCHERYL FOYTLIN
AddressJOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Apr-27-1982PUBLISHED FOR OPPOSITION   PUBOA
Jul-20-1982REGISTERED-PRINCIPAL REGISTER   R.PRA
Sep-14-1987REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
May-31-1988POST REGISTRATION ACTION MAILED - SEC. 8 & 15   PR23O
Jul-11-1988REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
Jan-27-1989REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Jul-17-2002PAPER RECEIVED   MAILI
Jul-17-2002REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Oct-05-2002REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Oct-05-2002REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Apr-08-2008CASE FILE IN TICRS   CFITO
May-31-2012TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
May-31-2012TEAS SECTION 8 & 9 RECEIVED   E89RI
Jun-11-2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jun-12-2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jun-12-2012REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Jun-12-2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E
Jul-20-2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Jun-23-2022TEAS SECTION 8 & 9 RECEIVED   E89RI
Jan-10-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-10-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jan-10-2023REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)   RNL3Q
Jan-10-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E